The ramifications of a U.S. tariff hike and Chinese retaliation continue to batter GE HealthCare's stock today, with news of an anti-dumping investigation adding a new wrinkle to its woes.

GE HealthCare Technologies (NasdaqGS:GEHC) saw its stock price rise by 2% over the last quarter. This gain coincides with the company's announcement of a distribution partnership with Probo Medical ...

The exact impact of "Liberation Day" may not be immediately clear, but it likely won't be as devastating for GE.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including QuidelOrtho (NASDAQ:QDEL) and its ...

Shares of the companies spun off from the former industrial icon General Electric were all tanking Friday, led by medical ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

GE HealthCare Technologies Inc.’s GEHC share price has dipped by 15.96%, which has investors questioning if this is right ...

Probo Medical ("Probo"), a global diagnostic imaging solutions provider, has announced its new distribution relationship with GE HealthCare. This relationship signifies a major milestone for Probo and ...

It's a global company, competing with leading healthcare equipment companies like Siemens ... 17,000 in the U.S.), including 7,000 in China, GE HealthCare is exposed to tariff actions in two ...

This was the stock's third consecutive day of losses.

The medtech giant expects to make about 70% of its products for the Indian market locally by 2030, a top executive said.

BAKU, Azerbaijan, April 3.​ The Ministry of Health of Azerbaijan hosted a meeting with the delegation of the American GE ...